CoChat

The association between body composition and overall survival in patients with advanced non-small cell lung cancer

Fu, Liang, Ding, Haiming, Mo, Liupei, Pan, Xiaoyu, Feng, Lijuan, Wen, Shenglian, Lan, Qiaoqing, Long, Liling · 2025 · Scientific Reports
Cited by 10

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-025-87073-w

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 52

  1. Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 72, 7–33 (2022). · DOI · Paper page
  2. Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021). · DOI · Paper page
  3. Chen, S. et al. Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol. 9, 465–472 (2023). · DOI · Paper page
  4. Herbst, R. S., Morgensztern, D. & Boshoff, C. The biology and management of non-small cell lung cancer. Nature. 553, 446–454 (2018). · DOI · Paper page
  5. Travis, W. D. et al. The 2015 world health organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification. J. Thorac. Oncol. 10, 1243–1260 (2015). · DOI · Paper page
  6. Nesbitt, J. C., Putnam, J. B. Jr., Walsh, G. L., Roth, J. A. & Mountain, C. F. Survival in early-stage non-small cell lung cancer. Ann. Thorac. Surg. 60, 466–472 (1995). · DOI · Paper page
  7. Shah, R., Sabanathan, S., Richardson, J., Mearns, A. J. & Goulden, C. Results of surgical treatment of stage I and II lung cancer. J. Cardiovasc. Surg. (Torino). 37, 169–172 (1996).
  8. Walters, S. et al. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: A population-based study, 2004–2007. Thorax. 68, 551–564 (2013). · DOI · Paper page
  9. Liu, C. et al. Arctigenin attenuates paraquat-induced human lung epithelial A549 cell injury by suppressing ROS/p38 mitogen-activated protein kinases-mediated apoptosis. World J. Emerg. Med. 13, 373–378 (2022). · DOI
  10. Traynor, S. et al. Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer. J. Immunother. Cancer https://doi.org/10.1136/jitc-2023-008759 (2024). · DOI
  11. Komuro, H. et al. Single-cell sequencing on CD8(+) TILs revealed the nature of exhausted T cells recognizing neoantigen and cancer/testis antigen in non-small cell lung cancer. J. Immunother. Cancer https://doi.org/10.1136/jitc-2023-007180 (2023). · DOI
  12. Jiang, X. et al. In-depth metaproteomics analysis of oral microbiome for lung cancer. Res. (Wash D C) https://doi.org/10.34133/2022/9781578 (2022). · DOI
  13. Detterbeck, F. C. et al. The IASLC lung cancer staging project: Background data and proposed criteria to distinguish separate primary lung cancers from metastatic foci in patients with two lung tumors in the forthcoming eighth edition of the TNM classification for lung cancer. J. Thorac. Oncol. 11, 651–665 (2016). · DOI · Paper page
  14. Stanley, K. E. Prognostic factors for survival in patients with inoperable lung cancer. J. Natl. Cancer Inst. 65, 25–32 (1980).
  15. Akamine, T. et al. Significance of the preoperative CONUT score in predicting postoperative disease-free and overall survival in patients with lung adenocarcinoma with obstructive lung disease. Anticancer Res. 37, 2735–2742 (2017). · doi:10.21873/anticanres.11625
  16. Sepesi, B., Correa, A. M., Dmitrovsky, E. & Liu, X. Reply to “influence of body mass index on overall survival following surgical resection of non-small cell lung cancer: Methodological issues”. J Thorac. Oncol. 12, e150–e151 (2017). · doi:10.1016/j.jtho.2017.07.003
  17. Fearon, K. et al. Definition and classification of cancer cachexia: An international consensus. Lancet Oncol. 12, 489–495 (2011). · DOI · Paper page
  18. Choi, H. et al. Association of adipopenia at preoperative PET/CT with mortality in stage i non-small cell lung cancer. Radiology. 301, 645–653 (2021). · DOI
  19. Prado, C. M. et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncol. 9, 629–635 (2008). · DOI · Paper page
  20. Caan, B. J., Cespedes Feliciano, E. M. & Kroenke, C. H. The importance of body composition in explaining the overweight paradox in cancer-counterpoint. Cancer Res. 78, 1906–1912 (2018). · DOI · Paper page
  21. Martin, L. et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J. Clin. Oncol. 31, 1539–1547 (2013). · DOI · Paper page
  22. Takamori, S. et al. Prognostic impact of postoperative skeletal muscle decrease in non-small cell lung cancer. Ann. Thorac. Surg. 109, 914–920 (2020). · DOI
  23. Tao, J. et al. Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non-small cell lung cancer. J. Cachexia Sarcopenia Muscle. 14, 2591–2601 (2023). · DOI
  24. Grønberg, B. H., Valan, C. D., Halvorsen, T., Sjøblom, B. & Jordhøy, M. S. Associations between severe co-morbidity and muscle measures in advanced non-small cell lung cancer patients. J. Cachexia Sarcopenia Muscle. 10, 1347–1355 (2019). · DOI
  25. Wang, G. N., Zhang, Z. M., Chen, W., Xu, X. Q. & Zhang, J. S. Timing of brain computed tomography for predicting neurological prognosis in comatose cardiac arrest survivors: A retrospective observational study. World J. Emerg. Med. 13, 349–354 (2022). · DOI
  26. Grønberg, B. H. et al. A comparison of CT based measures of skeletal muscle mass and density from the Th4 and L3 levels in patients with advanced non-small-cell lung cancer. Eur. J. Clin. Nutr. 73, 1069–1076 (2019). · DOI
  27. Garg, S. K. et al. Ectopic fat depots and coronary artery calcium in South Asians compared with other racial/ethnic groups. J. Am. Heart Assoc. https://doi.org/10.1161/JAHA.116.004257 (2016). · DOI
  28. Golubic, R. et al. Physical activity, sedentary time and gain in overall and central body fat: 7-year follow-up of the ProActive trial cohort. Int. J. Obes (Lond). 39, 142–148 (2015). · DOI · Paper page
  29. Zi, Y. et al. Fat content in lumbar paravertebral muscles: Quantitative and qualitative analysis using dual-energy CT in correlation to MR imaging. Eur. J. Radiol. 148, 110150 (2022). · DOI
  30. Guo, X., Yin, X., Liu, Z. & Wang, J. Non-Alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment. Int. J. Mol. Sci. https://doi.org/10.3390/ijms232415489 (2022). · DOI · Paper page
  31. Juge-Aubry, C. E., Henrichot, E. & Meier, C. A. Adipose tissue: A regulator of inflammation. Best Pract. Res. Clin. Endocrinol. Metab. 19, 547–566 (2005). · DOI · Paper page
  32. Ramos-Nino, M. E. The role of chronic inflammation in obesity-associated cancers. ISRN Oncol. 2013, 697521 (2013).
  33. Mungo, B. et al. Does obesity affect the outcomes of pulmonary resections for lung cancer? A national surgical quality improvement program analysis. Surgery. 157, 792–800 (2015). · DOI
  34. Thomas, P. A. et al. National perioperative outcomes of pulmonary lobectomy for cancer: The influence of nutritional status. Eur. J. Cardiothorac. Surg. 45, 652–659 (2014). · DOI
  35. Nattenmüller, J. et al. Prognostic impact of CT-quantified muscle and fat distribution before and after first-line-chemotherapy in lung cancer patients. PLoS One. 12, e0169136 (2017). · DOI
  36. Li, Y., Xie, Y. P., Li, X. M. & Lu, T. Effects of early standardized enteral nutrition on preventing acute muscle loss in the acute exacerbation of chronic obstructive pulmonary disease patients with mechanical ventilation. World J. Emerg. Med. 14, 193–197 (2023). · DOI
  37. Ebadi, M. & Mazurak, V. C. Evidence and mechanisms of fat depletion in cancer. Nutrients. 6, 5280–5297 (2014). · DOI · Paper page
  38. Rydén, M. et al. Lipolysis–not inflammation, cell death, or lipogenesis–is involved in adipose tissue loss in cancer cachexia. Cancer. 113, 1695–1704 (2008). · DOI · Paper page
  39. Lee, J. H. et al. Obesity is associated with improved postoperative overall survival, independent of skeletal muscle mass in lung adenocarcinoma. J. Cachexia Sarcopenia Muscle. 13, 1076–1086 (2022). · DOI
  40. Sun, C. et al. Combination of skeletal muscle mass and density predicts postoperative complications and survival of patients with non-small cell lung cancer. Ann. Surg. Oncol. 29, 1816–1824 (2022). · DOI
  41. Kim, E. Y. et al. Prognostic significance of radiodensity-based skeletal muscle quantification using preoperative CT in resected non-small cell lung cancer. J. Thorac. Dis. 13, 754–761 (2021). · DOI
  42. Scopel Poltronieri, T., de Paula, N. S. & Chaves, G. V. Skeletal muscle radiodensity and cancer outcomes: A scoping review of the literature. Nutr. Clin. Pract. 37, 1117–1141 (2022). · DOI
  43. Luo, Y. et al. Appropriateness of empirical antibiotic therapy in hospitalized patients with bacterial infection: A retrospective cohort study. Infect. Drug. Resist. 16, 4555–4568 (2023). · DOI
  44. Ramzee, A. F. et al. The impact of emergency department length of stay on the outcomes of trauma patients requiring hospitalization: A retrospective observational study. World J. Emerg. Med. 14, 96–105 (2023). · DOI
  45. Çınar, H. U., Çelik, B., Taşkın, G. & İnce, Ö. Impact of preoperative computed tomography-determined quantity and quality of skeletal muscle on survival after resected non-small cell lung carcinoma. Eur. J. Surg. Oncol. 48, 1937–1946 (2022). · DOI
  46. Lutz, C. T. & Quinn, L. S. Sarcopenia, obesity, and natural killer cell immune senescence in aging: Altered cytokine levels as a common mechanism. Aging (Albany NY). 4, 535–546 (2012). · DOI · Paper page
  47. Huang, M. et al. Use of veno-arterial extracorporeal membrane oxygenation ian the first successful combined lung-liver transplantation patient in China. World J. Emerg. Med. 13, 412–414 (2022). · doi:10.5847/wjem.j.1920-8642.2022.090
  48. Luo, Z. et al. Mechanisms of exercise in the treatment of lung cancer - a mini-review. Front. Immunol. 14, 1244764 (2023). · DOI
  49. Luo, Z. W. et al. Physical exercise reverses immuno-cold tumor microenvironment via inhibiting SQLE in non-small cell lung cancer. Mil. Med. Res. 10, 39 (2023).
  50. Shao, W. et al. Single-cell RNA sequencing reveals that MYBL2 in malignant epithelial cells is involved in the development and progression of ovarian cancer. Front. Immunol. 15, 1438198 (2024). · DOI
  51. Zhao, F. et al. Elucidating the role of tumor-associated ALOX5+ mast cells with transformative function in cervical cancer progression via single-cell RNA sequencing. Front. Immunol. 15, 1434450 (2024). · DOI
  52. Zhou, W., Lin, Z. & Tan, W. Deciphering the molecular landscape: Integrating single-cell transcriptomics to unravel myofibroblast dynamics and therapeutic targets in clear cell renal cell carcinomas. Front. Immunol. 15, 1374931 (2024). · DOI

Metadata

Authors
Fu, L., Ding, H., Mo, L., Pan, X., Feng, L., Wen, S., Lan, Q., & Long, L.
Venue
Scientific Reports
Published
2025-01-24
Volume
15
Issue
1
ISSN
2045-2322
Cited by
10
References
7
Language
en
Licence
Funders
the Innovation Project of Guangxi Graduate Education (YCBZ2023106)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The association between body composition and overall survival in patients with advanced non-small cell lung cancer. https://app.cochat.ai/papers/10.1038/s41598-025-87073-w
The paper
Fu, L., Ding, H., Mo, L., Pan, X., Feng, L., Wen, S., Lan, Q., & Long, L. (2025). The association between body composition and overall survival in patients with advanced non-small cell lung cancer. Scientific Reports. https://doi.org/10.1038/s41598-025-87073-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.